skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life

European Respiratory Journal, 2021-02, Vol.57 (3), p.2004015 [Peer Reviewed Journal]

The authors 2021. ;2021. This work is licensed under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright ©The authors 2021. 2021 ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.04015-2020 ;PMID: 33574080

Digital Resources/Online E-Resources

Citations Cited by
  • Title:
    Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life
  • Author: Anastasio, Fabio ; Barbuto, Sarah ; Scarnecchia, Elisa ; Cosma, Paolo ; Fugagnoli, Alessandro ; Rossi, Giulio ; Parravicini, Mirco ; Parravicini, Pierpaolo
  • Subjects: Original s
  • Is Part Of: European Respiratory Journal, 2021-02, Vol.57 (3), p.2004015
  • Description: Coronavirus disease 2019 (COVID-19) has spread worldwide determining a dramatic impact on the healthcare system. Aim of this study is to evaluate mid-term clinical impact of COVID-19 on respiratory function. 379 patients were evaluated 4 months after SARS-COV-2 diagnosis. Patients were divided in two groups based on the presence of pneumonia during COVID. Clinical conditions, quality of life, symptomatology, 6-min walking test, pulmonary function test with spirometry and diffusing capacity of carbon monoxide were analysed. Data were compared to clinical evolution during COVID (development of acute respiratory distress syndrome [ARDS], needing of invasive mechanical ventilation [IMV], partial oxygen saturation/ fraction of inspired oxygen [SpO /FiO ] ratio and pneumonia severity index [PSI]). After a median of 135 days, 260 (68.6%) of 379 patients referred almost one symptom. Patients who developed pneumonia during COVID-19 showed lower SpO at rest (p<0.001), SpO during 6-min walking test (p<0.001), total lung capacity (p<0.001), airway occlusion pressure after 0.1 s [P0.1] (p=0.02), P0.1/maximal inspiratory pressure [MIP] ratio (p=0.005) and higher Borg category-ratio scale (p=0.006) and modified Medical Research Council breathlessness scale (p=0.003), compared to patients without pneumonia. SpO /FiO ratio and PSI during SARS-COV-2 pneumonia were directly associated with mid-term alteration of partial oxygen saturation at rest (p<0.001), SpO during 6-min walking test (p<0.001), residual volume (p<0.001), total lung capacity (respectively p<0.001 and p=0.003) and forced vital capacity (respectively p=0.004, p=0.03). Lung damage during COVID-19 correlates to the reduction of pulmonary function after 4 months from acute infection.
  • Publisher: England: European Respiratory Society Journals Ltd
  • Language: English
  • Identifier: ISSN: 0903-1936
    EISSN: 1399-3003
    DOI: 10.1183/13993003.04015-2020
    PMID: 33574080
  • Source: Coronavirus Research Database
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait